Abstract
Ingenane diterpenoids are a subgroup of Euphorbia diterpenes characterized by a tetracyclic 5/7/7/3 ring system. Their structural diversity primarily arises from variable acylation and hydroxylation at defined positions of the ingenane scaffold, particularly C-3, C-5, C-13, C-16, C-17, and C-20. This review aimed to provide an updated overview of ingenane diterpenoids published from January 2020 to November 2025, with a focus on their sources, structural features, biological properties, and structure-activity relationships. These compounds possess a wide range of biological properties, including cytotoxic, chemo-sensitizing, dermatological, keratinocyte-targeted, etc. These activities are mediated through multiple mechanisms, such as mitochondrial apoptosis, protein kinase C modulation, ROS-dependent autophagy, NF-κB/MAPK/Nrf2 and SRC/PI3K/Akt signaling, and regulation of lipid metabolism. Overall, the reported findings highlight that the structural diversity of the ingenane scaffolds has a central role in shaping their varied bioactivities through multi-target mechanisms. Although ingenane diterpenoids are known for their dermatological applications, accumulating evidence reveals their broader therapeutic potential in cancer therapy, immune-related conditions, metabolic regulation, and agrochemical uses. Nevertheless, further systematic studies focusing on pharmacokinetic, toxicological, and molecular target-validation, and long-term safety are required to support their progression toward preclinical and clinical applications.